Ok, guess I can't debate that. Company says they are in talks; you say they are not. Curious, why do you think they are not? Do you work there? The market is there. Results are better than anything on market for B OM.
Also, regarding P, wasn't the purpose of phase 2a to test the oral delivery method?
There were positive results and from the May 24, 2016 announcement. ..
Pharmacokinetics/Pharmacodynamics (PK/PD) further revealed an early (by week 8) dose-related response that improved as treatment duration increased.